Tech Company Inital Public Offerings
Vitae Pharmaceuticals IPO
Vitae Pharmaceuticals, based in Fort Washington, had an IPO event on 9/24/2014.
Transaction Overview
Company Name
Announced On
9/24/2014
Transaction Type
IPO
Amount
$55,200,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
502 West Office Center Dr.
Fort Washington, PA 19034
USA
Fort Washington, PA 19034
USA
Phone
Website
Email Address
Overview
Vitae Pharmaceuticals (NADAQ: VTAE) is developing a robust and growing portfolio of novel product candidates generated by Contour, our proprietary computationally-based SBDD platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Hatfield
Chief Financial Officer
Richard Morris
Chief Medical Officer
Carole Sable
Chief Scientific Officer
Richard Gregg
VP - Bus. Development
Arthur Fratamico
Browse more venture capital transactions:
Prev: 9/24/2014: MatterFab venture capital transaction
Next: 9/24/2014: E la Carte venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs